Journals / The Journal of Pediatric Research / 2019 / Cilt: 6 - Sayı: 4

Evaluation of Resistance to Ciprofloxacin and Identification of Mutations in Topoisomerase Genes in Escherichia coli and Klebsiella pneumonia Isolated from Pediatric Urinary Tract Infections

Pages
322–328
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Then, polymerase chain reaction and sequencing were performed to investigate mutations in thegyrA and parC genes.Results: Overall, 15.3% of isolates of E. coli and K. pneumonia were resistant to ciprofloxacin.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Urinary tract infection (UTI) is one of the common infectious diseases of children.
📊
Key Findings & Data:However, recent reports suggested an increase in resistance tofluoroquinolones among bacteria causing UTI in children.
💡
Conclusion & Impact:Then, polymerase chain reaction and sequencing were performed to investigate mutations in thegyrA and parC genes.Results: Overall, 15.3% of isolates of E. coli and K. pneumonia were resistant to ciprofloxacin.
🔬Design:Research Article
📍Scope:2016-2017 Verileri
⚙️Variables:Domain Parameters

Özet

Aim: Urinary tract infection (UTI) is one of the common infectious diseases of children. Due to the limited use of fluoroquinolones in children,they still have no resistance problems as seen in the adult population. However, recent reports suggested an increase in resistance tofluoroquinolones among bacteria causing UTI in children. Therefore, the aim of this study is to evaluate the prevalence of Escherichia coli andKlebsiella pneumoniae isolates resistant to ciprofloxacin and to detect mutations in their gyrA and parC genes.Materials and Methods: The present study is conducted on 78 bacterial strains isolated from children with UTI during 2016-2017 at İmam RezaHospital in Kermanshah, Iran. The bacteria were identified based on microbiological methods and an antibiotic susceptibility test using discdiffusion and broth microdilution methods. Then, polymerase chain reaction and sequencing were performed to investigate mutations in thegyrA and parC genes.Results: Overall, 15.3% of isolates of E. coli and K. pneumonia were resistant to ciprofloxacin. Sequence analysis confirmed mutations inthe gyrA and parC genes in all of the isolates resistant to ciprofloxacin. The results showed changes in amino acids (ser83leu, ser83phe andAsp87Asn) in codons 83 and 87 in the quinolone resistance-determining regions of the gyrA gene, three substitutions in both the 80 and 84positions in the parC, ser80Ile, Glu84val and Glu84lys genes.Conclusion: The results of this study revealed resistance to ciprofloxacin in the pediatric population. Given that the use of ciprofloxacin inchildren is limited, this resistance cannot be due to antibiotic selective pressure. On the other hand, the mutations in the gyrA and parC genesin children was similar to that in adults which indicate that these resistant isolates can be transmitted from adults to children.

🔖

Cite This Article

GHADIRI, K., AKYA, A., ELAHI, A., JAFARİ, S., CHEGENELORESTANI, R. (2019). Evaluation of Resistance to Ciprofloxacin and Identification of Mutations in Topoisomerase Genes in Escherichia coli and Klebsiella pneumonia Isolated from Pediatric Urinary Tract Infections. The Journal of Pediatric Research, Cilt: 6 - Sayı: 4, 322–328. https://ajindex.com/articles/362908

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Barzan M, Hoseyni-Doust R, Ghalavand Z. Investigation of frequency and antimicrobial pattern of gram-negative bacteria isolated from urine specimens of children with urinary tract infection in Tehran, Iran. Iran J Med Microbiol 2016;9:99-104
  2. Amini F, Vaziri S, Karimpour HA, Hassani S, Mohamadi S, Azizi M. The study of frequency and antibiotic resistance pattern of urinary tract infection pathogens in children of Kermanshah in 2015. RJMS 2017;24:20-7
  3. Bader MS, Haeboldt J, Brooks A. Management of complicated urinary tract infection in the era of antimicrobial resistance. Post Grade Med 2010;122:7-15
  4. Choi SH, Kim EY, Kim YJ. Systemic use of fluoroquinolone in children. Korean J Pediatr 2013;56:196-201
  5. Edlin RS, Shapiro DJ, Hersh AL, Copp HL. Antibiotic resistance patterns of outpatient pediatric urinary tract infections. J Urol 2013;190:222-7
  6. Huang Y, Ogutu JO, Gu J, et al. Comparative Analysis of Quinolone Resistance in Clinical Isolates of Klebsiella pneumoniae and Escherichia coli from Chinese Children and Adults. Biomed Res Int 2015;2015:168292
  7. Hooper DC. Emerging mechanisms of fluoroquinolone resistance. Emerg Infect Dis 2001;7:337-41
  8. Bansal S, Tandon V. Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates. Int J Antimicrobial Agents 2011;37:253-5
  9. Ruiz J. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother 2003;51:1109-17
  10. Krishnan S, Balasubramanian D, Raju BA, Lakshmi BS. Use of a naturally occurring codon bias for identifying topoisomerase mutations in ciprofloxacin resistant Escherichia coli using PCR and future prospects with other bacterial genera: A pilot study. Adv Biol Chem 2012;2:366-71
  11. Fauci AS, Braunwald E, Kasper DL. Harrison’s principles of internal medicine. 17th ed. USA: McGraw-Hill; 2008
  12. Washington C, Stephen A, Janda W. Koneman’s color atlas and textbook of diagnostic microbiology. 6th ed. USA: Lippincott williams wilkins; 2006
  13. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. Supplement T-sI, editor. USA: CLSI; 2015
  14. Lindgren PK, Karlsson A, Hughes D. Mutation rate and evolution of fluoroquinolon resistance in Escherichia coli Isolates from patients with urinary tract infection. Antimicrob Agents Chemother 2003:3222-32
  15. Park YH, Yoo JH, Huh DH, Cho YK, Choi J